img

Global Long-Acting Reversible Contraception(LARC) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Long-Acting Reversible Contraception(LARC) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
Global Long-Acting Reversible Contraception(LARC) market is projected to reach US$ 1730.6 million in 2029, increasing from US$ 1154 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Age 20~24 Years Old and Age 25-34 Years Old are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Long-Acting Reversible Contraception(LARC) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
Merck
Teva Pharmaceutical
Allergan
HRA Pharma
Eurogine
Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
Wuxi Tianyi Medical Equipment Co., Ltd.
SMB Corporation
Shenyang Liren
Tianjin Hejie Medical Equipment Co., Ltd.
Cooper Companies
AbbVie Allergan
Organon
Shanghai Dahua Pharmaceutical
Segment by Type
Intrauterine Devices (IUCs)
Subcutaneous Implant

Segment by Application


Age 20~24 Years Old
Age 25-34 Years Old
Age 35~44 Years Old
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Long-Acting Reversible Contraception(LARC) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Long-Acting Reversible Contraception(LARC), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Long-Acting Reversible Contraception(LARC) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Long-Acting Reversible Contraception(LARC) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Long-Acting Reversible Contraception(LARC) introduction, etc. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Long-Acting Reversible Contraception(LARC) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Long-Acting Reversible Contraception(LARC) Market Overview
1.1 Long-Acting Reversible Contraception(LARC) Product Overview
1.2 Long-Acting Reversible Contraception(LARC) Market Segment by Type
1.2.1 Intrauterine Devices (IUCs)
1.2.2 Subcutaneous Implant
1.3 Global Long-Acting Reversible Contraception(LARC) Market Size by Type
1.3.1 Global Long-Acting Reversible Contraception(LARC) Market Size Overview by Type (2018-2029)
1.3.2 Global Long-Acting Reversible Contraception(LARC) Historic Market Size Review by Type (2018-2024)
1.3.3 Global Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Long-Acting Reversible Contraception(LARC) Sales Breakdown by Type (2018-2024)
1.4.2 Europe Long-Acting Reversible Contraception(LARC) Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Long-Acting Reversible Contraception(LARC) Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Breakdown by Type (2018-2024)
2 Global Long-Acting Reversible Contraception(LARC) Market Competition by Company
2.1 Global Top Players by Long-Acting Reversible Contraception(LARC) Sales (2018-2024)
2.2 Global Top Players by Long-Acting Reversible Contraception(LARC) Revenue (2018-2024)
2.3 Global Top Players by Long-Acting Reversible Contraception(LARC) Price (2018-2024)
2.4 Global Top Manufacturers Long-Acting Reversible Contraception(LARC) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Long-Acting Reversible Contraception(LARC) Market Competitive Situation and Trends
2.5.1 Long-Acting Reversible Contraception(LARC) Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Long-Acting Reversible Contraception(LARC) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-Acting Reversible Contraception(LARC) as of 2022)
2.7 Date of Key Manufacturers Enter into Long-Acting Reversible Contraception(LARC) Market
2.8 Key Manufacturers Long-Acting Reversible Contraception(LARC) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Long-Acting Reversible Contraception(LARC) Status and Outlook by Region
3.1 Global Long-Acting Reversible Contraception(LARC) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Long-Acting Reversible Contraception(LARC) Historic Market Size by Region
3.2.1 Global Long-Acting Reversible Contraception(LARC) Sales in Volume by Region (2018-2024)
3.2.2 Global Long-Acting Reversible Contraception(LARC) Sales in Value by Region (2018-2024)
3.2.3 Global Long-Acting Reversible Contraception(LARC) Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Region
3.3.1 Global Long-Acting Reversible Contraception(LARC) Sales in Volume by Region (2024-2029)
3.3.2 Global Long-Acting Reversible Contraception(LARC) Sales in Value by Region (2024-2029)
3.3.3 Global Long-Acting Reversible Contraception(LARC) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Long-Acting Reversible Contraception(LARC) by Application
4.1 Long-Acting Reversible Contraception(LARC) Market Segment by Application
4.1.1 Age 20~24 Years Old
4.1.2 Age 25-34 Years Old
4.1.3 Age 35~44 Years Old
4.1.4 Other
4.2 Global Long-Acting Reversible Contraception(LARC) Market Size by Application
4.2.1 Global Long-Acting Reversible Contraception(LARC) Market Size Overview by Application (2018-2029)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Historic Market Size Review by Application (2018-2024)
4.2.3 Global Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Long-Acting Reversible Contraception(LARC) Sales Breakdown by Application (2018-2024)
4.3.2 Europe Long-Acting Reversible Contraception(LARC) Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Long-Acting Reversible Contraception(LARC) Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Breakdown by Application (2018-2024)
5 North America Long-Acting Reversible Contraception(LARC) by Country
5.1 North America Long-Acting Reversible Contraception(LARC) Historic Market Size by Country
5.1.1 North America Long-Acting Reversible Contraception(LARC) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2018-2024)
5.1.3 North America Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2018-2024)
5.2 North America Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Country
5.2.1 North America Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2024-2029)
5.2.2 North America Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2024-2029)
6 Europe Long-Acting Reversible Contraception(LARC) by Country
6.1 Europe Long-Acting Reversible Contraception(LARC) Historic Market Size by Country
6.1.1 Europe Long-Acting Reversible Contraception(LARC) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2018-2024)
6.1.3 Europe Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2018-2024)
6.2 Europe Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Country
6.2.1 Europe Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2024-2029)
6.2.2 Europe Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2024-2029)
7 Asia-Pacific Long-Acting Reversible Contraception(LARC) by Region
7.1 Asia-Pacific Long-Acting Reversible Contraception(LARC) Historic Market Size by Region
7.1.1 Asia-Pacific Long-Acting Reversible Contraception(LARC) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Region
7.2.1 Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales in Value by Region (2024-2029)
8 Latin America Long-Acting Reversible Contraception(LARC) by Country
8.1 Latin America Long-Acting Reversible Contraception(LARC) Historic Market Size by Country
8.1.1 Latin America Long-Acting Reversible Contraception(LARC) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2018-2024)
8.1.3 Latin America Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2018-2024)
8.2 Latin America Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Country
8.2.1 Latin America Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2024-2029)
9 Middle East and Africa Long-Acting Reversible Contraception(LARC) by Country
9.1 Middle East and Africa Long-Acting Reversible Contraception(LARC) Historic Market Size by Country
9.1.1 Middle East and Africa Long-Acting Reversible Contraception(LARC) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Long-Acting Reversible Contraception(LARC) Forecasted Market Size by Country
9.2.1 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Long-Acting Reversible Contraception(LARC) Products Offered
10.1.5 Bayer Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Long-Acting Reversible Contraception(LARC) Products Offered
10.2.5 Merck Recent Development
10.3 Teva Pharmaceutical
10.3.1 Teva Pharmaceutical Company Information
10.3.2 Teva Pharmaceutical Introduction and Business Overview
10.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Products Offered
10.3.5 Teva Pharmaceutical Recent Development
10.4 Allergan
10.4.1 Allergan Company Information
10.4.2 Allergan Introduction and Business Overview
10.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Allergan Long-Acting Reversible Contraception(LARC) Products Offered
10.4.5 Allergan Recent Development
10.5 HRA Pharma
10.5.1 HRA Pharma Company Information
10.5.2 HRA Pharma Introduction and Business Overview
10.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.5.4 HRA Pharma Long-Acting Reversible Contraception(LARC) Products Offered
10.5.5 HRA Pharma Recent Development
10.6 Eurogine
10.6.1 Eurogine Company Information
10.6.2 Eurogine Introduction and Business Overview
10.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eurogine Long-Acting Reversible Contraception(LARC) Products Offered
10.6.5 Eurogine Recent Development
10.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
10.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
10.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Introduction and Business Overview
10.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Products Offered
10.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Development
10.8 Wuxi Tianyi Medical Equipment Co., Ltd.
10.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
10.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Introduction and Business Overview
10.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Products Offered
10.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Recent Development
10.9 SMB Corporation
10.9.1 SMB Corporation Company Information
10.9.2 SMB Corporation Introduction and Business Overview
10.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.9.4 SMB Corporation Long-Acting Reversible Contraception(LARC) Products Offered
10.9.5 SMB Corporation Recent Development
10.10 Shenyang Liren
10.10.1 Shenyang Liren Company Information
10.10.2 Shenyang Liren Introduction and Business Overview
10.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Shenyang Liren Long-Acting Reversible Contraception(LARC) Products Offered
10.10.5 Shenyang Liren Recent Development
10.11 Tianjin Hejie Medical Equipment Co., Ltd.
10.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Information
10.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Introduction and Business Overview
10.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Products Offered
10.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Recent Development
10.12 Cooper Companies
10.12.1 Cooper Companies Company Information
10.12.2 Cooper Companies Introduction and Business Overview
10.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Cooper Companies Long-Acting Reversible Contraception(LARC) Products Offered
10.12.5 Cooper Companies Recent Development
10.13 AbbVie Allergan
10.13.1 AbbVie Allergan Company Information
10.13.2 AbbVie Allergan Introduction and Business Overview
10.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.13.4 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Products Offered
10.13.5 AbbVie Allergan Recent Development
10.14 Organon
10.14.1 Organon Company Information
10.14.2 Organon Introduction and Business Overview
10.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Organon Long-Acting Reversible Contraception(LARC) Products Offered
10.14.5 Organon Recent Development
10.15 Shanghai Dahua Pharmaceutical
10.15.1 Shanghai Dahua Pharmaceutical Company Information
10.15.2 Shanghai Dahua Pharmaceutical Introduction and Business Overview
10.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Products Offered
10.15.5 Shanghai Dahua Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Long-Acting Reversible Contraception(LARC) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Long-Acting Reversible Contraception(LARC) Industrial Chain Analysis
11.4 Long-Acting Reversible Contraception(LARC) Market Dynamics
11.4.1 Long-Acting Reversible Contraception(LARC) Industry Trends
11.4.2 Long-Acting Reversible Contraception(LARC) Market Drivers
11.4.3 Long-Acting Reversible Contraception(LARC) Market Challenges
11.4.4 Long-Acting Reversible Contraception(LARC) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Long-Acting Reversible Contraception(LARC) Distributors
12.3 Long-Acting Reversible Contraception(LARC) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Intrauterine Devices (IUCs)
Table 2. Major Company of Subcutaneous Implant
Table 3. Global Long-Acting Reversible Contraception(LARC) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 5. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (US& Million)
Table 7. Global Long-Acting Reversible Contraception(LARC) Market Share in Value by Type (2018-2024)
Table 8. Global Long-Acting Reversible Contraception(LARC) Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (K Units)
Table 10. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Type (2024-2029)
Table 13. Global Long-Acting Reversible Contraception(LARC) Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (K Units)
Table 15. North America Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2018-2024)
Table 17. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2018-2024)
Table 21. Latin America Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Long-Acting Reversible Contraception(LARC) Sales by Company (2018-2024) & (K Units)
Table 25. Global Long-Acting Reversible Contraception(LARC) Sales Share by Company (2018-2024)
Table 26. Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Company (2018-2024)
Table 28. Global Market Long-Acting Reversible Contraception(LARC) Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Long-Acting Reversible Contraception(LARC) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Long-Acting Reversible Contraception(LARC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-Acting Reversible Contraception(LARC) as of 2022)
Table 32. Date of Key Manufacturers Enter into Long-Acting Reversible Contraception(LARC) Market
Table 33. Key Manufacturers Long-Acting Reversible Contraception(LARC) Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Long-Acting Reversible Contraception(LARC) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024) & (K Units)
Table 37. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Region (2018-2024)
Table 40. Global Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029) & (K Units)
Table 42. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Region (2024-2029)
Table 45. Global Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Long-Acting Reversible Contraception(LARC) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (K Units)
Table 48. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application (2018-2024)
Table 51. Global Long-Acting Reversible Contraception(LARC) Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (K Units)
Table 53. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application (2024-2029)
Table 56. Global Long-Acting Reversible Contraception(LARC) Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) (K Units)
Table 58. North America Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) (K Units)
Table 60. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) (K Units)
Table 64. Latin America Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 68. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2018-2024)
Table 71. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 72. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 76. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 80. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Country (2024-2029)
Table 107. Bayer Company Information
Table 108. Bayer Introduction and Business Overview
Table 109. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Long-Acting Reversible Contraception(LARC) Product
Table 111. Bayer Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Long-Acting Reversible Contraception(LARC) Product
Table 116. Merck Recent Development
Table 117. Teva Pharmaceutical Company Information
Table 118. Teva Pharmaceutical Introduction and Business Overview
Table 119. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product
Table 121. Teva Pharmaceutical Recent Development
Table 122. Allergan Company Information
Table 123. Allergan Introduction and Business Overview
Table 124. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Allergan Long-Acting Reversible Contraception(LARC) Product
Table 126. Allergan Recent Development
Table 127. HRA Pharma Company Information
Table 128. HRA Pharma Introduction and Business Overview
Table 129. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. HRA Pharma Long-Acting Reversible Contraception(LARC) Product
Table 131. HRA Pharma Recent Development
Table 132. Eurogine Company Information
Table 133. Eurogine Introduction and Business Overview
Table 134. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Eurogine Long-Acting Reversible Contraception(LARC) Product
Table 136. Eurogine Recent Development
Table 137. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
Table 138. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Introduction and Business Overview
Table 139. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
Table 141. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Development
Table 142. Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
Table 143. Wuxi Tianyi Medical Equipment Co., Ltd. Introduction and Business Overview
Table 144. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
Table 146. Wuxi Tianyi Medical Equipment Co., Ltd. Recent Development
Table 147. SMB Corporation Company Information
Table 148. SMB Corporation Introduction and Business Overview
Table 149. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. SMB Corporation Long-Acting Reversible Contraception(LARC) Product
Table 151. SMB Corporation Recent Development
Table 152. Shenyang Liren Company Information
Table 153. Shenyang Liren Introduction and Business Overview
Table 154. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product
Table 156. Shenyang Liren Recent Development
Table 157. Tianjin Hejie Medical Equipment Co., Ltd. Company Information
Table 158. Tianjin Hejie Medical Equipment Co., Ltd. Introduction and Business Overview
Table 159. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
Table 161. Tianjin Hejie Medical Equipment Co., Ltd. Recent Development
Table 162. Cooper Companies Company Information
Table 163. Cooper Companies Introduction and Business Overview
Table 164. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Cooper Companies Long-Acting Reversible Contraception(LARC) Product
Table 166. Cooper Companies Recent Development
Table 167. AbbVie Allergan Company Information
Table 168. AbbVie Allergan Introduction and Business Overview
Table 169. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product
Table 171. AbbVie Allergan Recent Development
Table 172. Organon Company Information
Table 173. Organon Introduction and Business Overview
Table 174. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Organon Long-Acting Reversible Contraception(LARC) Product
Table 176. Organon Recent Development
Table 177. Shanghai Dahua Pharmaceutical Company Information
Table 178. Shanghai Dahua Pharmaceutical Introduction and Business Overview
Table 179. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product
Table 181. Shanghai Dahua Pharmaceutical Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Long-Acting Reversible Contraception(LARC) Market Trends
Table 185. Long-Acting Reversible Contraception(LARC) Market Drivers
Table 186. Long-Acting Reversible Contraception(LARC) Market Challenges
Table 187. Long-Acting Reversible Contraception(LARC) Market Restraints
Table 188. Long-Acting Reversible Contraception(LARC) Distributors List
Table 189. Long-Acting Reversible Contraception(LARC) Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-Acting Reversible Contraception(LARC) Product Picture
Figure 2. Global Long-Acting Reversible Contraception(LARC) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Long-Acting Reversible Contraception(LARC) Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Long-Acting Reversible Contraception(LARC) Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Intrauterine Devices (IUCs)
Figure 6. Global Intrauterine Devices (IUCs) Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Subcutaneous Implant
Figure 8. Global Subcutaneous Implant Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type in 2022 & 2029
Figure 11. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type in 2022
Figure 12. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Type in 2022
Figure 13. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type in 2022
Figure 14. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Type in 2022
Figure 17. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-Acting Reversible Contraception(LARC) Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-Acting Reversible Contraception(LARC) Revenue in 2022
Figure 23. Long-Acting Reversible Contraception(LARC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Age 20~24 Years Old
Figure 25. Global Age 20~24 Years Old Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Age 25-34 Years Old
Figure 27. Global Age 25-34 Years Old Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Age 35~44 Years Old
Figure 29. Global Age 35~44 Years Old Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application in 2022 & 2029
Figure 34. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Application in 2022
Figure 35. North America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application in 2022
Figure 36. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Application in 2022
Figure 37. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application in 2022
Figure 40. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Long-Acting Reversible Contraception(LARC) Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Long-Acting Reversible Contraception(LARC) Manufacturing Cost Structure
Figure 45. Long-Acting Reversible Contraception(LARC) Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed